By BEN LEONARD,
RUTH READER and
ERIN SCHUMAKER March 22, 2023
Source: Politico
Photo Source: Unsplash,
03/22/2023 02:00 PM EDT
TECH MAZE
Regulators should come with money, Garcia says, if they want to impose mandates. | Courtesy of Greg Garcia
Greg Garcia helps health care organizations partner with the government in the fight against hackers.
The members of the Healthcare and Public Health Sector Coordinating Council’s Cybersecurity Working Group that he leads — health systems, insurers and health tech companies, among others — face serious threats.
Those threats include ransomware attacks that jeopardize patient safety and bottom lines.
Ben caught up with Garcia to discuss new guidance his group helped write with the Department of Health and Human Services on cybersecurity standards and the possibility that Congress will mandate minimum security procedures for health care organizations.
How do you assess the level of adoption of cybersecurity best practices?
Adoption is constantly increasing.
What we’re trying to do is get the small and mid-sized organizations to up their game.
What are the biggest barriers for them?
We’re working to bear down on how they’re getting beat. What are the vulnerabilities or lack of controls that hackers are exploiting?
Email security is one of the most basic ones. Another one is the need for multifactor authentication. Things like that are fairly simple. Not everything takes a lot of money.
The bigger issue with the small hospitals is that we are still in the post-pandemic or near-post-pandemic environment. The existential questions these hospitals have to go through — cybersecurity does not always rise to the top of their priority list.
Senate Intelligence Chair Mark Warner is mulling legislation that could set minimum cybersecurity standards for health organizations. What do you think about that?
We have minimum standards. Whether or not the government wants to make them mandatory, that’s going to be up to them.
If you’re going to regulate us, show us the money. The government can provide reimbursement incentives, subsidies and outright grants. Let’s think creatively about that.
CHECKUP
Allowing residents to meet with out-of-state doctors has worked out well in Florida and Idaho, according to a new report. | AP
Experiments in loosening medical-licensing rules have worked out well for patients in Idaho and Florida, a new study contends.
The report from the Cicero Institute, an entrepreneurship-focused think tank in Austin, Texas, aims to make a case for continuing to allow patients to meet virtually with out-of-state doctors.
That’s something many states permitted during the pandemic by waiving state licensing rules, and they’re now deciding whether to continue.
The Cicero Institute found little reason not to.
It reported:
— Florida officials have received just 16 patient complaints since the state legislature approved cross-state telemedicine in 2019, and officials have taken no disciplinary actions against telehealth providers.
— In Idaho, GOP Gov. Brad Little’s decision to allow cross-state telemedicine in 2020 has also had virtually no pushback from patients in the form of formal complaints.
Those results should reassure policymakers, said Josh Archambault, a senior fellow at the Cicero Institute who wrote the report with Harvard telemedicine researcher Ateev Mehrotra.
“The big takeaway is that telehealth is not sparking more patient concerns than in-person care,” Archambault said.
FOLLOW THE MONEY
Researchers are examining whether magic mushrooms can treat depression | AP
Advocates of decriminalizing psychedelics believe the evidence supports their medicinal use to treat diseases like depression and post-traumatic stress disorder.
In their campaign to convince government that’s true, some of psychedelics’ proponents are hoping that helping politicians fund their own campaigns will prove mutually beneficial.
The Psychedelic Medicine PAC will contribute to candidates who support more research to buttress the case for prescribing psychedelic therapy.
Among the drugs the PAC promotes are:
— MDMA, a stimulant more commonly known as ecstasy, which the Food and Drug Administration is examining as a possible treatment for post-traumatic stress disorder
— Psilocybin, better known as magic mushrooms, which is in clinical trials for treating depression
— Ketamine, which the FDA approved decades ago as an anesthetic and, more recently, as a nasal spray version treating depression
Melissa Lavasani, a co-founder of the PAC, used psilocybin to recover from postpartum depression and helped convince Washington, D.C., voters in 2020 to decriminalize the substance.
How can such practices impact your health? How? Why?
Share the wealth of health with your family and friends by sharing this article with 3 people today.
If this article was helpful to you, donate to the Shidonna Raven Garden and Cook E-Magazine Today. Thank you in advance.
Comments